Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasedienol in Social Anxiety Disorder
NCT02622958Phase 3Completed
- Sponsor
- Pherin Pharmaceuticals
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fasedienol in Social Anxiety Disorder (SAD), sponsored by Pherin Pharmaceuticals. Started Mar 2014; status: completed.
02
Drugs
fasedienol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT02622958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622958.